title: [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
abstract: Betalactamase-producing organisms are responsible for an increasing number of ENT and lower respiratory tract infections. Or cephalosporins and the combination of amoxicillin with the beta-lactamase inhibitor clavulanic acid are alternatives to ampicillin therapy. The killing activity of cefadroxil on the organisms most often responsible for ENT and respiratory infections was evaluated in vitro using a viable bacteria count method, comparatively with cefaclor, josamycin, and amoxicillin-clavulanic acid. Killing activity was found to be time-dependent for all the antimicrobial agents studied. Cefadroxil exhibited the same bactericidal effect on Streptococcus pyogenes and S. pneumoniae than the other agents. Haemophilus influenzae and an increasing number of Pneumococcus strains were resistant to josamycin which is therefore not appropriate for first-line therapy. As compared with amoxicillin and amoxicillin-clavulanic acid, cefadroxil was less active on H. influenzae and more active on Staphylococcus aureus. Production of beta-lactamase failed to influence the killing activity of cefadroxil. These bacteriologic data, together with results of pharmacologic studies (long half-life and good penetration within tissues) can explain the clinical successes obtained with cefadroxil in ENT and lower respiratory tract infections.
authors.affiliation: Service des Maladies Infectieuses, Hôpital de l'Archet, Nice, France.
authors.forename: H
authors.initials: H
authors.lastname: Etesse-Carsenti
authors.forename: J
authors.initials: J
authors.lastname: Caillon
authors.forename: V
authors.initials: V
authors.lastname: Mondain
authors.forename: J
authors.initials: J
authors.lastname: Durant
authors.forename: E
authors.initials: E
authors.lastname: Bernard
authors.forename: P
authors.initials: P
authors.lastname: Dellamonica
authors.forename: H B
authors.initials: HB
authors.lastname: Drugeon
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002433:Cefaclor / Q000494:pharmacology*; D002434:Cefadroxil / Q000494:pharmacology*; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D006193:Haemophilus influenzae / Q000187:drug effects; D015570:Josamycin / Q000494:pharmacology*; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
chemical_list: D002969:Clavulanic Acids; D004338:Drug Combinations; D002434:Cefadroxil; D002433:Cefaclor; D000658:Amoxicillin; D015570:Josamycin
vernacular_title: Activité bactéricide du céfadroxil comparée à celle de l'amoxicilline-acide clavulanique, du céfaclor et de la josamycine.